News
SHWGF
0.690
NaN%
--
Shandong Weigao Group Postpones EGM and Alters Book Closure Dates
TipRanks · 4d ago
Shandong Weigao Group Announces Extraordinary General Meeting for Key Resolutions
TipRanks · 4d ago
Shandong Weigao Group Renews Continuing Connected Transactions
TipRanks · 11/28 15:10
Shandong Weigao Forms Joint Venture to Expand in Indonesian Market
TipRanks · 11/10 09:37
Shandong Weigao Group Reports Q3 Revenue Growth Amid Segment Challenges
TipRanks · 11/03 09:09
Shandong Weigao Announces Strategic Transaction with WEGO Prefills
TipRanks · 10/31 12:41
Shandong Weigao Group Announces Regulatory Compliance Update
TipRanks · 10/30 10:14
Morgan Stanley Sticks to Its Hold Rating for Shandong Weigao Group Medical Polymer Co (SHWGF)
TipRanks · 10/23 11:32
Shandong Weigao Group Announces Potential Acquisition to Expand Business Scope
TipRanks · 10/17 12:38
Shandong Weigao Approves Key Resolutions at Extraordinary General Meeting
TipRanks · 10/17 10:08
Shandong Weigao Announces Interim Dividend for 2025
TipRanks · 10/17 10:08
Shandong Weigao Group Announces Board Composition
Barchart · 10/11 04:18
Shandong Weigao Announces Interim Dividend for H1 2025
Barchart · 10/04 03:42
Shandong Weigao Group Announces EGM for Share Incentive Scheme and Dividend
Barchart · 10/03 10:22
Shandong Weigao Reschedules Extraordinary General Meeting
TipRanks · 10/02 11:09
Shandong Weigao Group Proposes Amendments and H Share Full Circulation
TipRanks · 09/29 11:37
Shandong Weigao Announces Director Resignation
TipRanks · 09/29 09:39
More
Webull provides a variety of real-time SHWGF stock news. You can receive the latest news about Shandong Weigao through multiple platforms. This information may help you make smarter investment decisions.
About SHWGF
Shandong Weigao Group Medical Polymer Co Ltd is a China-based company principally engaged in the research and development, production and sale of medical device products. The Company operates its businesses through six segments. The Medical Device segment produces and sells clinical care, medical testing, anesthesia and surgical related products and other consumables. The Orthopaedic Products segment produces and sells orthopaedic products, including tissue repair product line. The Interventional Products segment produces and sells tumour and blood vessel interventional instruments. The Pharma Packaging Products segment produces and sells pre-filled syringes and flushing syringes. The Blood Management Products segment produces and sells blood collection, irradiation, storage, separation and sterilization products. The Others segment engages in finance lease and factoring business. The Company mainly operates its businesses in the domestic and overseas markets.